KRISTY STOKES: Open Payments
NPI 1154180925 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 99 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $1,875 · 2025 $2,297
Food & beverage: $2,281Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $258 |
| Tandem Diabetes Care, Inc. | 4 | $251 |
| Ascendis Pharma Endocrinology Inc | 13 | $249 |
| SANOFI-AVENTIS U.S. LLC | 6 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $171 |
| Lilly USA, LLC | 8 | $141 |
| Amgen Inc. | 5 | $133 |
| Corcept Therapeutics | 4 | $108 |
| Madrigal Pharmaceuticals | 3 | $93 |
| Radius Health, Inc. | 3 | $85 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Yorvipath, TZIELD, Kerendia, Ozempic, TEPEZZA, Korlym, JARDIANCE.
Industry payments across GA — which companies pay providers there.
